Authors: SHAW PM SIVANANDHAM M BERNIK SF DITARANTO K WALLACK MK

Citation: Pm. Shaw et al., ADJUVANT IMMUNOTHERAPY FOR PATIENTS WITH MELANOMA - ARE PATIENTS WITHMELANOMA OF THE HEAD AND NECK CANDIDATES FOR THIS THERAPY, Head & neck, 19(7), 1997, pp. 595-603

Authors: WALLACK MK SIVANANDHAM M DITARANTO K SHAW P BALCH CM URIST MM BLAND KI MURRAY D ROBINSON WA FLAHERTY L RICHARDS JM ROSEN L BARTOLUCCI AA

Citation: Mk. Wallack et al., INCREASED SURVIVAL OF PATIENTS TREATED WITH A VACCINIA MELANOMA ONCOLYSATE VACCINE - 2ND INTERIM ANALYSIS OF DATA FROM A PHASE-III, MULTIINSTITUTIONAL TRIAL, Annals of surgery, 226(2), 1997, pp. 198-206

Authors: WALLACK MK SIVANANDHAM M WHOOLEY B DITARANTO K BARTOLUCCI AA

Citation: Mk. Wallack et al., FAVORABLE CLINICAL-RESPONSES IN SUBSETS OF PATIENTS FROM A RANDOMIZED, MULTIINSTITUTIONAL MELANOMA VACCINE TRIAL, Annals of surgical oncology, 3(2), 1996, pp. 110-117